| CCAAT/enhancer-binding proteins: structure, function and regulation DP Ramji, P Foka Biochemical Journal 365 (3), 561-575, 2002 | 1742 | 2002 |
| Lipoprotein lipase: structure, function, regulation, and role in disease JR Mead, SA Irvine, DP Ramji Journal of molecular medicine 80, 753-769, 2002 | 1185 | 2002 |
| Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets DP Ramji, TS Davies Cytokine & growth factor reviews 26 (6), 673-685, 2015 | 552 | 2015 |
| Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy JE McLaren, DR Michael, TG Ashlin, DP Ramji Progress in lipid research 50 (4), 331-347, 2011 | 495 | 2011 |
| The key role of apolipoprotein E in atherosclerosis K Greenow, NJ Pearce, DP Ramji Journal of molecular medicine 83, 329-342, 2005 | 319 | 2005 |
| Interferon gamma: a master regulator of atherosclerosis JE McLaren, DP Ramji Cytokine & growth factor reviews 20 (2), 125-135, 2009 | 311 | 2009 |
| IL-33 reduces macrophage foam cell formation JE McLaren, DR Michael, RC Salter, TG Ashlin, CJ Calder, AM Miller, ... The Journal of Immunology 185 (2), 1222-1229, 2010 | 250 | 2010 |
| The two C/EBP isoforms, IL6DBP/NFIL6 and CEBP6δ/NFIL63, are induced by IL6β to promote acute phase gene transcription via different mechanisms DP Ramji, A Vitelli, F Tronche, R Cortese, G Ciliberto Nucleic acids research 21 (2), 289-294, 1993 | 228* | 1993 |
| Nutraceutical therapies for atherosclerosis JWE Moss, DP Ramji Nature Reviews Cardiology 13 (9), 513-532, 2016 | 191 | 2016 |
| Interferon-γ and atherosclerosis: pro-or anti-atherogenic? EJ Harvey, DP Ramji Cardiovascular research 67 (1), 11-20, 2005 | 183 | 2005 |
| The role of transforming growth factor-β in atherosclerosis NN Singh, DP Ramji Cytokine & growth factor reviews 17 (6), 487-499, 2006 | 169 | 2006 |
| Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets JWE Moss, DP Ramji Future medicinal chemistry 8 (11), 1317-1330, 2016 | 137 | 2016 |
| The pivotal role of lipoprotein lipase in atherosclerosis JR Mead, DP Ramji Cardiovascular research 55 (2), 261-269, 2002 | 137 | 2002 |
| Promoter elements and factors involved in hepatic transcription of the human ApoA-I gene positive and negative regulators bind to overlapping sites. P Papazafiri, K Ogami, DP Ramji, A Nicosia, P Monaci, C Cladaras, ... Journal of Biological Chemistry 266 (9), 5790-5797, 1991 | 132 | 1991 |
| The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis ML Buckley, DP Ramji Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (7 …, 2015 | 130 | 2015 |
| ERK is integral to the IFN-γ–mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages N Li, JE McLaren, DR Michael, M Clement, CA Fielding, DP Ramji The Journal of Immunology 185 (5), 3041-3048, 2010 | 119 | 2010 |
| Protein kinase CK2, an important regulator of the inflammatory response? NN Singh, DP Ramji Journal of molecular medicine 86, 887-897, 2008 | 116 | 2008 |
| Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines TS Tengku-Muhammad, TR Hughes, H Ranki, A Cryer, DP Ramji Cytokine 12 (9), 1430-1436, 2000 | 115 | 2000 |
| ADAMTS proteases: key roles in atherosclerosis? RC Salter, TG Ashlin, APL Kwan, DP Ramji Journal of molecular medicine 88, 1203-1211, 2010 | 109 | 2010 |
| Lipoprotein lipase, a key role in atherosclerosis? JR Mead, A Cryer, DP Ramji FEBS letters 462 (1-2), 1-6, 1999 | 108 | 1999 |
Jennifer PikeCardiff UniversityVerified email at cardiff.ac.uk
